GenoMed - Diagnósticos de Medicina Molecular, S.A. was founded in 2004 as a spin-off company of iMM. GenoMed mission’s is to create value through leveraging scientific and technological knowledge in molecular biology and genetics, and to provide cutting-edge solutions for molecular diagnosis in human medicine. Currently, GenoMed offers over 480 different tests that are used in diagnosis, prognosis and therapeutic follow-up. GenoMed works in two main areas of medicine and in one non-clinical area:
Oncology: tests for solid tumors such as Lung Cancer (including liquid biopsy for T790M mutation and NGS panels), Colorectal Cancer (including liquid biopsy), Central Nervous System Tumors, Melanoma, Breast Cancer, among others. Cytogenetic tests are also available for Lung Cancer and Central Nervous System Tumors. Moreover, GenoMed provides molecular (including NGS panels) and cytogenetics tests for hemato-oncological diseases.
Genetic Diseases and Pharmacogenetics: GenoMed provides more than 100 NGS panels in almost all medical specialties such as Cardiology (e.g. Cardiomyopathies, Long QT Syndrome, Brugada Syndrome, Familial Hypercholesterolemia, etc), Neurology (e.g. Alzheimer disease and Frontotemporal dementia, Parkinson Disease, among others), Hereditary Cancers (Breast, Pancreas, Colon, for example), Metabolic Diseases (e.g. Hereditary Porphyrias or Maturity-onset diabetes of the young – MODY). Sanger Sequencing is also available for the diagnosis of diseases such as Wilson Disease, Thrombophilia or Hereditary Hemochromatosis.
Paternity tests and Genealogies: paternity tests with legal validity are provided. Tests for genetic ancestry (maternal and paternal) are also available.
Chair Scientific Advisory Board: Maria Carmo-Fonseca